Legal & General Group PLC Viking Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 118,371 shares of VKTX stock, worth $6.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118,371
Previous 118,371 -0.0%
Holding current value
$6.23 Million
Previous $7.49 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$49.84 - $70.47 $385,811 - $545,508
7,741 Added 7.0%
118,371 $7.49 Million
Q2 2024

Aug 14, 2024
BUY
$47.39 - $80.2 $679,714 - $1.15 Million
14,343 Added 14.9%
110,630 $5.86 Million
Q1 2024

May 14, 2024
BUY
$17.4 - $94.5 $13,589 - $73,804
781 Added 0.82%
96,287 $7.9 Million
Q4 2023

Feb 15, 2024
BUY
$9.24 - $19.64 $8,371 - $17,793
906 Added 0.96%
95,506 $1.78 Million
Q3 2023

Nov 14, 2023
SELL
$10.92 - $16.0 $2,205 - $3,232
-202 Reduced 0.21%
94,600 $1.05 Million
Q2 2023

Aug 14, 2023
BUY
$14.84 - $24.79 $957,076 - $1.6 Million
64,493 Added 212.78%
94,802 $1.54 Million
Q1 2023

May 15, 2023
BUY
$8.08 - $17.33 $244,896 - $525,254
30,309 New
30,309 $504,000
Q2 2022

Aug 22, 2022
SELL
$2.11 - $3.15 $52,178 - $77,896
-24,729 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$5.58 - $7.04 $72,668 - $91,681
13,023 Added 111.25%
24,729 $156,000
Q2 2021

Aug 12, 2021
BUY
$5.19 - $6.73 $2,740 - $3,553
528 Added 4.72%
11,706 $70,000
Q1 2021

May 17, 2021
BUY
$5.74 - $9.67 $22,380 - $37,703
3,899 Added 53.57%
11,178 $70,000
Q3 2020

Nov 13, 2020
SELL
$5.73 - $8.11 $15,339 - $21,710
-2,677 Reduced 26.89%
7,279 $42,000
Q2 2020

Aug 14, 2020
BUY
$4.35 - $8.08 $2,583 - $4,799
594 Added 6.34%
9,956 $72,000
Q1 2020

May 14, 2020
SELL
$3.45 - $7.95 $11,474 - $26,441
-3,326 Reduced 26.21%
9,362 $44,000
Q4 2019

Feb 13, 2020
BUY
$6.38 - $8.73 $6,258 - $8,564
981 Added 8.38%
12,688 $102,000
Q1 2019

May 15, 2019
BUY
$7.58 - $9.94 $7,602 - $9,969
1,003 Added 9.37%
11,707 $116,000
Q4 2018

Feb 15, 2019
BUY
$7.16 - $16.21 $21,086 - $47,738
2,945 Added 37.96%
10,704 $82,000
Q3 2018

Nov 20, 2018
BUY
$9.7 - $19.65 $12,260 - $24,837
1,264 Added 19.46%
7,759 $135,000
Q2 2018

Aug 10, 2018
BUY
$3.88 - $12.74 $25,200 - $82,746
6,495 New
6,495 $62,000

Others Institutions Holding VKTX

# of Institutions
474
Shares Held
66.2M
Call Options Held
5.72M
Put Options Held
3.39M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.03B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email